Literature DB >> 8746298

Women and smoking.

A Amos1.   

Abstract

Smoking kills over half a million women each year and is the most important preventable cause of female premature death in several developed countries. However, in many countries, cigarette smoking still tends to be regarded as a mainly male problem. This paper explores the reasons why more attention needs to be paid to issues around smoking and women, even in countries which currently have low levels of female cigarette smoking. The article includes an overview of current patterns and trends of smoking among women, and the factors which influence smoking uptake and cessation in women compared to men. The experience of countries with the longest history of widespread female smoking is used to identify some of the key challenges facing developed and developing countries. Tobacco companies have identified women as a key target group, therefore particular attention is given to the ways in which they have attempted to reach women through advertising and other marketing strategies. It is concluded that in order to halt and ultimately reverse the tobacco epidemic among women, tobacco control policies need to encompass both gender-specific and gender-sensitive approaches. Examples are given of the types of action that are needed in relation to research, public policy and legislation, and education.

Entities:  

Mesh:

Year:  1996        PMID: 8746298     DOI: 10.1093/oxfordjournals.bmb.a011534

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  27 in total

1.  From social taboo to "torch of freedom": the marketing of cigarettes to women.

Authors:  A Amos; M Haglund
Journal:  Tob Control       Date:  2000-03       Impact factor: 7.552

2.  Increased mortality among Danish women: population based register study.

Authors:  K Juel
Journal:  BMJ       Date:  2000-08-05

3.  Tobacco smoking among school children in Colombo district, Sri Lanka.

Authors:  Prasad Katulanda; Isurujith Kongala Liyanage; Kremlin Wickramasinghe; Indunil Piyadigama; Indika M Karunathilake; Paula H Palmer; David R Matthews
Journal:  Asia Pac J Public Health       Date:  2012-03-16       Impact factor: 1.399

4.  Educational inequalities in initiation, cessation, and prevalence of smoking among 3 Italian birth cohorts.

Authors:  Bruno Federico; Giuseppe Costa; Anton E Kunst
Journal:  Am J Public Health       Date:  2006-06-29       Impact factor: 9.308

Review 5.  Smoking cessation in women. Special considerations.

Authors:  K A Perkins
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

6.  Impact of female cigarette smoking on circulating B cells in vivo: the suppressed ICOSLG, TCF3, and VCAM1 gene functional network may inhibit normal cell function.

Authors:  Feng Pan; Tie-Lin Yang; Xiang-Ding Chen; Yuan Chen; Ge Gao; Yao-Zhong Liu; Yu-Fang Pei; Bao-Yong Sha; Yan Jiang; Chao Xu; Robert R Recker; Hong-Wen Deng
Journal:  Immunogenetics       Date:  2010-03-09       Impact factor: 2.846

7.  The Virginia Slims identity crisis: an inside look at tobacco industry marketing to women.

Authors:  B A Toll; P M Ling
Journal:  Tob Control       Date:  2005-06       Impact factor: 7.552

8.  Trends in cigarette smoking in 36 populations from the early 1980s to the mid-1990s: findings from the WHO MONICA Project.

Authors:  A Molarius; R W Parsons; A J Dobson; A Evans; S P Fortmann; K Jamrozik; K Kuulasmaa; V Moltchanov; S Sans; J Tuomilehto; P Puska
Journal:  Am J Public Health       Date:  2001-02       Impact factor: 9.308

Review 9.  "Asian yuppies...are always looking for something new and different": creating a tobacco culture among young Asians.

Authors:  J Knight; S Chapman
Journal:  Tob Control       Date:  2004-12       Impact factor: 7.552

Review 10.  Latin America and the Caribbean: assessment of the advances in public health for the achievement of the Millennium Development Goals.

Authors:  Amal K Mitra; Gisela Rodriguez-Fernandez
Journal:  Int J Environ Res Public Health       Date:  2010-05-06       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.